Patents by Inventor Alane M. Gray

Alane M. Gray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD22 antibodies and immunoconjugates and methods of use
    Patent number: 8968741
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: March 3, 2015
    Assignee: Genentech, Inc.
    Inventors: Allen J. Ebens, Alane M. Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • Human nerve growth factor by recombinant technology
    Patent number: 8557768
    Abstract: The ?-subunit of human nerve growth factor (?NGF) is prepared in essentially pure form in commercially useful quantities using recombinant DNA technology. The nucleotide sequence and vectors encoding human ?NGF and host cells transformed with the vectors are also provided. The ?NGF which the invention provides is useful, for example, in treating nerve damage.
    Type: Grant
    Filed: April 4, 1995
    Date of Patent: October 15, 2013
    Assignee: Genentech, Inc.
    Inventors: Alane M. Gray, Axel Ullrich
  • Antibodies and immunoconjugates and uses therefor
    Patent number: 8524865
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: September 3, 2013
    Assignee: Genentech, Inc.
    Inventors: Allen J. Ebens, Jr., Alane M. Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
    Publication number: 20130171170
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Application
    Filed: June 12, 2012
    Publication date: July 4, 2013
    Applicant: GENENTECH, INC.
    Inventors: ALLEN J. EBENS, JR., ALANE M. GRAY, WEI-CHING LIANG, YAN WU, SHANG-FAN YU
  • Anti-CD22 antibodies and immunoconjugates and methods of use
    Patent number: 8394607
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: March 12, 2013
    Assignee: Genentech, Inc.
    Inventors: Allen J. Ebens, Jr., Alane M. Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • Anti-CD22 Antibodies And Immunoconjugates and Methods of Use
    Publication number: 20120329094
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Application
    Filed: July 26, 2012
    Publication date: December 27, 2012
    Applicant: Genentech, Inc.
    Inventors: Allen J. Ebens, JR., Alane M. Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • Antibodies and immunoconjugates and uses therefor
    Patent number: 8226945
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: July 24, 2012
    Assignee: Genentech, Inc.
    Inventors: Allen J. Ebens, Jr., Alane M. Gray, Wei-Ching Liang, Yan Wu, Shang-Fan Yu
  • ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
    Publication number: 20110142859
    Abstract: Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.
    Type: Application
    Filed: November 4, 2010
    Publication date: June 16, 2011
    Applicant: GENENTECH, INC.
    Inventors: ALLEN J. EBENS, JR., ALANE M. GRAY, WEI-CHING LIANG, YAN WU, SHANG-FAN YU
  • Human nerve growth factor by recombinant technology
    Patent number: 5288622
    Abstract: The .beta.-subunit of human nerve growth factor (.beta.NGF) is prepared in essentially pure form in commercially viable quantities using recombinant DNA technology. The nucleotide sequence and vectors encoding human .beta.NGF and host cells transformed with the vectors are also provided.
    Type: Grant
    Filed: June 11, 1992
    Date of Patent: February 22, 1994
    Assignee: Genentech, Inc.
    Inventors: Alane M. Gray, Axel Ullrich
  • Human nerve growth factor by recombinant technology
    Patent number: 5169762
    Abstract: The .beta.-subunit of human nerve growth factor (.beta.NGF) is prepared in essentially pure form in commercially viable quantities using recombinant DNA technology. The nucleotide sequence and vectors encoding human .beta.NGF and host cells transformed with the vectors are also provided.
    Type: Grant
    Filed: September 8, 1988
    Date of Patent: December 8, 1992
    Assignee: Genentech, Inc.
    Inventors: Alane M. Gray, Axel Ullrich